Sibylle Junge

Efficacy and safety of lumacaftor and ivacaftor in patients aged 6–11 years with cystic fibrosis homozygous for F508del-CFTR : a randomised, placebo-controlled phase 3 trial

Félix Ratjen, Christopher Hug, Gautham Marigowda et al. · The Lancet Respiratory Medicine · 2017 · 295 citations

Medicine, Pediatrics, Pharmacotherapy +12

Quality of life is associated with physical activity and fitness in cystic fibrosis

Helge Hebestreit, Kerstin Schmid, Stephanie Kieser et al. · BMC Pulmonary Medicine · 2014 · 149 citations · Full text

Education, Rehabilitation Medicine, Health-related Fitness +16

Physical activity is independently related to aerobic capacity in cystic fibrosis

Helge Hebestreit, Stephanie Kieser, Stefan G. Rüdiger et al. · European Respiratory Journal · 2006 · 140 citations · Full text

Education, Physiology, Exercise Testing +16

Long-term effects of a partially supervised conditioning programme in cystic fibrosis

Helge Hebestreit, Stephanie Kieser, Sibylle Junge et al. · European Respiratory Journal · 2009 · 137 citations · Full text

Education, Health Promotion, Rehabilitation Medicine +17

Effect of supervised training on FEV1 in cystic fibrosis: A randomised controlled trial

Susi Kriemler, Stephanie Kieser, Sibylle Junge et al. · Journal of Cystic Fibrosis · 2013 · 100 citations · Full text

Health Professions, Kinesiology, Diagnostic Assessment +9